Company / Net Income
BioNexus Gene Lab Corp Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$3.0M
FY2025
5-year range
-$3.0M / $751.6K
FY2021-FY2025
Trend
-86.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 7 years, ranging from -$3M in FY2025 to $1M in FY2020.
Based on SEC 10-K filings.
-$3M in FY2025.
Declined from -$3M to -$3M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 86.7% year-over-year.
- Peak net income was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.0M | -86.7% |
| FY2024 | -$1.6M | +39.2% |
| FY2023 | -$2.6M | -638.6% |
| FY2022 | -$356.0K | -147.4% |
| FY2021 | $751.6K | -31.3% |
| FY2020 | $1.1M | +543.9% |
| FY2019 | -$246.5K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026